Our formulations are a testimony to the production from our state-of-the-art facilities. Our commitment to provide affordable formulations to the last man in the society makes all the difference. We are committed to care for the patients and society at large. Our basket of finished formulations contains more than 200+ products in several forms belonging to 45 therapeutic segments and 12 specialties, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics, immunologicals, and oncology. Our formulation business fulfils the need for domestic, regulated, and the rest of the world markets.

Our globally accredited, state-of-the-art manufacturing facilities in Dholka (Gujarat), Samba (Jammu and Kashmir), and Addis Ababa (Ethiopia) produce almost all dosage forms including sterile as well as non-sterile products. Our new greenfield manufacturing facility in Udaipur (Rajasthan) specialises in Lyophilised formulations.
85+ countries supply,
including domestic (India), Europe, USA and the rest of the world
Globally accredited by

Caters to
Dedicated Manufacturing Blocks
Penicillin, Cephalosporin, Rifampicin, and Herbal products.
Various Dosage Forms
Tablets, hard gelatin capsules, oral liquids, small-volume liquid injectables, and lyophilised injections.
Accredited by


Caters to
Various Dosage Forms
Tablets, soft gelatin capsules, liquids, and oral.
Accredited by


Facility
The Greenfield injectables manufacturing facility spans 45 acres.
200 vials/min.
Filling Line Capacity
Approx 8.32 million
Plant’s Annual Capacity


Various Dosage Forms
Oral solids and liquids.
Accredited by
Only WHO-cGMP-compliant facility in Ethiopia.


Contact Us
Our Story
Businesses
Therapies
Corporate Identification No : U24231GJ1991PLC015132
©2026 Cadila Pharmaceuticals. All rights reserved